Author:
Afkhami Mohammed,Hassanpour Ali,Fairweather Michael,Njobuenwu Derrick O.
Reference20 articles.
1. Mealtime rapid-acting inhaled insulin (Exubera®) improves glycemic control in patients with type 2 diabetes failing combination oral agents: A 3-month, randomized, comparative trial;Rosenstock;Diabetes,2002
2. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 1 diabetes: Results of a 6-month, randomized, comparative trial;Quattrin;Diabetes Care,2004
3. Efficacy and safety of inhaled insulin (Exubera) compared with subcutaneous insulin therapy in patients with type 2 diabetes: Results of a 6-month, randomized, comparative trial;Hollander;Diabetes Care,2004
4. Advanced approaches in insulin delivery;Shaikh;Current Pharmaceutical Biotechnology,2005
5. Time to peak insulin level, relative bioavailability, and effect of site of deposition of nebulized insulin in patients with noninsulin-dependent diabetes mellitus;Laube;Journal of Aerosol Medicine,1998
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献